{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3610, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 72, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/72", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-72", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 73, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/73", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-73", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 74, "slideType": "cover", "function": "front_matter", "notes": "Includes code snippets as decorative background elements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/74", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-74", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 75, "slideType": "agenda", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/75", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-75", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 76, "slideType": "team_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/76", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-76", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 77, "slideType": "key_messages", "function": "present_framework", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/77", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-77", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 78, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a process flow framework to show the integration of AI across the drug development lifecycle.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/78", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-78", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 79, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide outlines a proprietary workflow combining AI-driven design with experimental validation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/79", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-79", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 80, "slideType": "before_after", "function": "illustrate_case", "notes": "The slide uses a split-screen layout to contrast project objectives with results.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/80", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-80", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 81, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide uses a dot plot to show binding affinity vs sequence diversity and a bar chart to compare binding rates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/81", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-81", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 82, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide shows two dose-response curves (Cell Surface Binding and ADCC) and two molecular surface models for epitope mapping.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/82", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-82", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 83, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a Gantt-style chart to illustrate the overlap of two batches of targets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/83", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-83", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 84, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a process flow framework to show the progression from target discovery to optimized antibodies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/84", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-84", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 85, "slideType": "other", "function": "present_framework", "notes": "The slide features a circular flywheel diagram on the left and a breakdown of the wet lab validation process on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/85", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-85", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 86, "slideType": "before_after", "function": "illustrate_case", "notes": "The slide uses molecular visualization of RBD mutations and a table showing KD (binding affinity) values, highlighting the poor binding (607 nM) to the beta variant.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/86", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-86", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 87, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a two-step process flow (1 and 2) to explain the technical methodology of their AI-driven drug discovery platform.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/87", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-87", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 88, "slideType": "other", "function": "analyze_data", "notes": "The slide uses a process flow (1 -> 2) followed by a scatter plot validation and a summary table of Pearson R values.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/88", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-88", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 89, "slideType": "propose_solution", "function": "analyze_data", "notes": "SPR stands for Surface Plasmon Resonance. The charts show binding affinity (KD) comparisons.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/89", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-89", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 90, "slideType": "before_after", "function": "illustrate_case", "notes": "The slide uses a process diagram to show the AI workflow and a table to quantify the binding affinity (nM KD) improvements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/90", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-90", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 91, "slideType": "thesis_headline", "function": "present_solution", "notes": "The slide uses a consistent visual metaphor of a Y-shaped antibody binding to three distinct targets in each of the three columns.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/91", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-91", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 92, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a 5-column layout with icons to represent different capabilities of the platform.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/92", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-92", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 93, "slideType": "cover", "function": "front_matter", "notes": "Includes pseudo-code snippets in the background.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/93", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-93", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 94, "slideType": "nominee_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/94", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-94", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 95, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/95", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-95", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 96, "slideType": "roadmap", "function": "plan_implementation", "notes": "The chart uses a horizontal bar format to represent development progress. Color coding distinguishes between 'Potential First in Class' (blue) and 'Potential Best in Class' (red).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/96", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-96", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 97, "slideType": "thesis_headline", "function": "size_opportunity", "notes": "Includes a biological pathway diagram (Takedatsu 2008) and market data points.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/97", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-97", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 98, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The scatter plot shows a Pearson R of 0.74 for N=5389 data points.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/98", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-98", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 99, "slideType": "propose_solution", "function": "present_solution", "notes": "The chart is a dot plot showing affinity (KD) vs edit distance from parent binder. The benchmark is a horizontal dashed line.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/99", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-99", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 100, "slideType": "other", "function": "present_solution", "notes": "The slide uses a side-by-side comparison structure to detail the value proposition of two specific drug candidates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/100", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-100", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 101, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide illustrates a dual-pathway process leading to a unified AI-driven optimization step.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/101", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-101", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 102, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Includes a Kaplan-Meier survival curve and a biological diagram of TLS.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/102", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-102", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 103, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide outlines a proprietary R&D workflow for antibody discovery.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/103", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-103", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 104, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/104", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-104", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 105, "slideType": "other", "function": "illustrate_case", "notes": "The slide illustrates a scientific workflow for target discovery.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/105", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-105", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 106, "slideType": "propose_solution", "function": "present_solution", "notes": "The chart shows a dose-dependent increase in absorbance for ABS-301 compared to isotype controls, suggesting binding/inhibition activity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/106", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-106", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 107, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a combination of a horizontal bar chart and a data table to quantify the addressable market.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/107", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-107", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 108, "slideType": "roadmap", "function": "present_solution", "notes": "The chart uses a horizontal bar format to represent development progress against a timeline of stages (Target Eval to IND).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/108", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-108", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 109, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/109", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-109", "loopMatches": [], "arcBeatMatches": [ { "to": 111, "from": 109, "beatId": "e6b2e023-8998-45e3-8419-81aaa960723a", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation concludes with a call to action and a final thought, leaving the audience with a sense of satisfaction.", "position": 4, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 110, "slideType": "closing_ask", "function": "state_next_steps", "notes": "The slide uses code snippets as decorative background elements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/110", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-110", "loopMatches": [], "arcBeatMatches": [ { "to": 111, "from": 109, "beatId": "e6b2e023-8998-45e3-8419-81aaa960723a", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation concludes with a call to action and a final thought, leaving the audience with a sense of satisfaction.", "position": 4, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e061-72f9-baa2-90171b05eced", "docSlug": "cdaaa50efb264b4a4093f665bafb20a4", "documentTitle": "Absci | Investor Presentation Deck | 111 slides", "authorId": "absci", "authorName": "Absci", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 111, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/111", "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced", "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-111", "loopMatches": [], "arcBeatMatches": [ { "to": 111, "from": 109, "beatId": "e6b2e023-8998-45e3-8419-81aaa960723a", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation concludes with a call to action and a final thought, leaving the audience with a sense of satisfaction.", "position": 4, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "The slide features a split design with a white left side containing logos and a dark purple abstract background on the right.", "imagePath": "https://imgproxy.kitesheet.com/0DmB7O5C1luLQ2ukdFPCMIoqJcEu2HQU_Tb3M9RspD4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ODE5ZjM1MTJlNTY1YjkxOGM2Y2ZjOGUzNjg4Y2ZiMi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/1", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/UHkw1DJhbHDgJIqg-Fv5IYzvFoWMTcSflMfdJvpS9GY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ODE5ZjM1MTJlNTY1YjkxOGM2Y2ZjOGUzNjg4Y2ZiMi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/c6S8btX99JzENyx6g-D_GENXc713KzbVV1dkPlj6DrE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ODE5ZjM1MTJlNTY1YjkxOGM2Y2ZjOGUzNjg4Y2ZiMi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/WKm9GRKQrQujzlpqlsc-kxBEbH3_llPpWGlGA1b_IPY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85ODE5ZjM1MTJlNTY1YjkxOGM2Y2ZjOGUzNjg4Y2ZiMi9wMDAxLnBuZw" }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/2", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style chart to show the development stage of multiple drug programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/3", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 3, "beatId": "9e92e950-6d7d-4a39-aa35-77037b50a0b7", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "Targeting new heights in the treatment of IBD, Potential best-in-class lead programs", "position": 2, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "product_demo", "function": "present_solution", "notes": "The slide uses a three-column layout to compare product candidates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/4", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 3, "beatId": "9e92e950-6d7d-4a39-aa35-77037b50a0b7", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "Targeting new heights in the treatment of IBD, Potential best-in-class lead programs", "position": 2, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "problem_statement", "function": "frame_problem", "notes": "The chart is a scatter plot showing maintenance remission rates vs. dosing frequency, positioning current therapies in a cluster and the company's target in a superior quadrant.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/5", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-5", "loopMatches": [ { "to": 6, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "1e678675-b00f-4ca4-9628-1ea0d4fbdd6f", "evidence": "Despite advances, new approaches are needed to break the efficacy ceiling and improve convenience of biologics", "position": 0, "objective": "What are the consequences of not addressing unmet needs in IBD?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 5, "beatId": "d3d060f4-a6ef-45ba-9081-b2065408160d", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Despite advances, new approaches are needed to break the efficacy ceiling and improve convenience of biologics", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a three-column layout to present the company's core technological approaches.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/6", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-6", "loopMatches": [ { "to": 6, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "1e678675-b00f-4ca4-9628-1ea0d4fbdd6f", "evidence": "Despite advances, new approaches are needed to break the efficacy ceiling and improve convenience of biologics", "position": 0, "objective": "What are the consequences of not addressing unmet needs in IBD?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 6, "from": 6, "beatId": "08639147-5bfb-445c-a16c-e908eaca73ea", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Our strategy is built on three validated approaches to address unmet needs in IBD", "position": 1, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "roadmap", "function": "plan_implementation", "notes": "The chart uses a horizontal bar representation to indicate progress through discovery and IND-enabling stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/7", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-7", "loopMatches": [ { "to": 8, "from": 7, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "f1b337db-6c6a-4ce5-ac0d-8b7da161a10f", "evidence": "Spyre is building a potentially best-in-class IBD pipeline with next-generation mAbs and rational combinations", "position": 1, "objective": "Can Spyre Therapeutics' pipeline deliver a best-in-class IBD treatment?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "cover", "function": "front_matter", "notes": "The slide uses a split-screen layout with a photo of a person on the right and branding on the left.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/8", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-8", "loopMatches": [ { "to": 8, "from": 7, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "f1b337db-6c6a-4ce5-ac0d-8b7da161a10f", "evidence": "Spyre is building a potentially best-in-class IBD pipeline with next-generation mAbs and rational combinations", "position": 1, "objective": "Can Spyre Therapeutics' pipeline deliver a best-in-class IBD treatment?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/9", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 9, "beatId": "4a654b29-f8fd-4689-809f-c704cc8af64b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "SPY001 potency & selectivity matches vedolizumab, SPY001 has exhibited ~2x the half-life of vedolizumab in NHPs", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "Includes structural biology visualization, dose-response curves, and a binding affinity table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/10", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 9, "beatId": "4a654b29-f8fd-4689-809f-c704cc8af64b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "SPY001 potency & selectivity matches vedolizumab, SPY001 has exhibited ~2x the half-life of vedolizumab in NHPs", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "Pharmacokinetic study results showing extended half-life for the drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/11", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 9, "beatId": "4a654b29-f8fd-4689-809f-c704cc8af64b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "SPY001 potency & selectivity matches vedolizumab, SPY001 has exhibited ~2x the half-life of vedolizumab in NHPs", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines a standard clinical trial progression for SAD and MAD cohorts, including randomization ratios and participant types.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/12", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/13", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes PK modeling data comparing human and NHP half-lives and steady-state concentration simulations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/14", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "comparison_table", "function": "compare_peers", "notes": "Uses icon-based visualization to represent injection frequency.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/15", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a bar chart to show dose-response correlation and a line chart to show pharmacokinetic modeling.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/16", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a timeline-like visual to compare dosing schedules at weeks 0, 2, and 6.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/17", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses two distinct data visualizations: a table for clinical safety metrics and a bar chart for ADA rates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/18", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/19", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-e109-770f-8f32-3054686041b6", "docSlug": "9819f3512e565b918c6cfc8e3688cfb2", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Spyre Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "cover", "function": "front_matter", "notes": "Features a stylized antibody icon overlay on a photo of a person.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/20", "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6", "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }